Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

Share Price is delayed by 15 minutes
Get Live Data
525.00    15.00 (2.94%)
Bid:
523.00
Ask:
527.00
Spread: 4.00 (0.765%)
Market Cap: £302.10m
MAB1 Live PriceLast checked at - London Stock Exchange

Intraday Mortgage Advice Bureau Share Chart

AGM Trading Statement

20 May 2026 07:00

RNS Number : 9774E
Mortgage Advice Bureau (Hldgs) PLC
20 May 2026
 

20 May 2026

Mortgage Advice Bureau (Holdings) plc

("MAB" or the "Company")

 

AGM Trading Statement

 

Mortgage Advice Bureau (Holdings) plc (LSE: MAB1), a leading technology-driven UK property finance service, will hold its Annual General Meeting at 12:30pm today during which Michael Jones, Chair, will make the following statement:

"On 27 April 2026, alongside publication of its prospectus, the Company reported that it had entered 2026 with good momentum, with mortgage applications in the first 16 weeks of 2026 19% higher year-on-year.

This positive momentum has continued, with mortgage applications in the first 19 weeks of 2026 15% higher year-on-year, in line with the Board's expectations. During March and April, a period of heightened macroeconomic and interest rate uncertainty led to four weeks of accelerated refinancing activity, as customers moved to fix rates early ahead of their product expiry dates. Application levels have since normalised, with refinancing activity expected to remain robust through the remainder of 2026.

The Company's customer acquisition and retention strategies are supporting continued growth in lead flow, underpinning MAB's long track record of year-on-year revenue growth across all market conditions."

 

Enquiries:

Investor Relations investor.relations@mab.org.uk

Camarco mab@camarco.co.uk

 

About MAB:

MAB is a leading UK property finance platform that connects customers, advisers, lenders, and insurers throughout the homeownership journey. Through its scalable, technology-driven intermediary model, MAB delivers personalised mortgage and protection advice via its proprietary platform, supported by deep customer insight and a data-rich, digitally enabled framework.

Through its partner firms, known as Appointed Representatives (ARs), MAB has over 2,100 advisers providing expert advice across mortgages, specialist lending, protection and general insurance products. MAB supports its AR firms with proprietary technology and services, including adviser recruitment and lead generation, learning and development, compliance auditing and supervision, and digital marketing and website solutions.

For more information, visit www.mortgageadvicebureau.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAUKANRNBUVAAR
Date   Source Headline
25th Jul 20197:00 amRNSTrading Statement
17th Jul 201911:57 amRNSNational Employee Mortgage Advice Service Launch
15th Jul 20193:44 pmRNSDirector/PDMR Shareholding
11th Jul 20195:37 pmRNSHolding(s) in Company
10th Jul 201910:00 amRNSExercise of Options and Director/PDMR Shareholding
8th Jul 201912:07 pmRNSSecond Price Monitoring Extn
8th Jul 201912:02 pmRNSPrice Monitoring Extension
2nd Jul 20198:52 amRNSGrant of options and Director dealing
28th Jun 20193:57 pmRNSDirector/PDMR Shareholding
18th Jun 20197:05 amRNSAcquisition of 80% interest in First Mortgage
14th Jun 20195:40 pmRNSDirector/PDMR Shareholding
31st May 20194:32 pmRNSDirector/PDMR Shareholding
28th May 201910:49 amRNSHolding(s) in Company
21st May 20193:57 pmRNSResult of AGM
21st May 20197:00 amRNSAGM Statement
16th May 20198:34 amRNSDirector/PDMR Shareholding
30th Apr 20192:43 pmRNSDirector/PDMR Shareholding
24th Apr 20197:00 amRNSExecutive Director Updates
16th Apr 20194:57 pmRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSPosting of Report and Accounts and Notice of AGM
4th Apr 20194:40 pmRNSSecond Price Monitoring Extn
4th Apr 20194:35 pmRNSPrice Monitoring Extension
29th Mar 201912:10 pmRNSDirector/PDMR Shareholding
29th Mar 20199:33 amRNSBlock Admission Application
21st Mar 20198:13 amRNSHolding(s) in Company
21st Mar 20198:12 amRNSHolding(s) in Company
19th Mar 20197:00 amRNSFinal Results for the year ended 31 December 2018
14th Mar 20194:50 pmRNSDirector/PDMR Shareholding
6th Mar 20197:00 amRNSHolding(s) in Company
5th Mar 201912:13 pmRNSHolding(s) in Company
28th Feb 20191:41 pmRNSDirector/PDMR Shareholding
25th Feb 20194:35 pmRNSPrice Monitoring Extension
21st Feb 20194:59 pmRNSHolding(s) in Company
14th Feb 20195:54 pmRNSDirector/PDMR Shareholding
31st Jan 20194:21 pmRNSDirector/PDMR Shareholding
30th Jan 20198:32 amRNSHolding(s) in Company
25th Jan 201910:39 amRNSNew Investor Website
22nd Jan 20197:00 amRNSTrading Update
21st Jan 20197:00 amRNSDirectorate Change
14th Jan 20195:30 pmRNSFaroe Petroleum
14th Jan 20195:24 pmRNSDirector/PDMR Shareholding
31st Dec 201810:52 amRNSDirector/PDMR Shareholding
17th Dec 20187:02 amRNSDirector/PDMR Shareholding
30th Nov 20181:16 pmRNSDirector/PDMR Shareholding
23rd Nov 20184:35 pmRNSPrice Monitoring Extension
14th Nov 20185:54 pmRNSDirector/PDMR Shareholding
31st Oct 20183:35 pmRNSDirector/PDMR Shareholding
29th Oct 20189:13 amRNSDirector/PDMR Shareholding
23rd Oct 20187:00 amRNSHolding(s) in Company
17th Oct 20187:00 amRNSReplacement: Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.